UnitedHealthcare Announces Zero Cost Sharing For Insulin As Legislative Relief Faces Challenges

Private sector efforts to lower cost sharing for insulin continue but patient advocates and lawmakers still believe legislation is needed to tackle the issue in a comprehensive way.

Public Pressure Drives Private Payer Action But Is It Enough? • Source: Shutterstock

UnitedHealthcare is joining other national payers and pharmacy benefit managers in offering cost sharing relief for insulin in the private insurance market as US lawmakers work to move legislation capping copays at $35 per fill.

United's program will eliminate all cost sharing (copays and deductibles) for certain short- and long-acting insulins in the insurer’s standard...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access